Date Initiated by Firm | April 16, 2012 |
Date Posted | April 30, 2012 |
Recall Status1 |
Terminated 3 on February 19, 2013 |
Recall Number | Z-1477-2012 |
Recall Event ID |
61635 |
510(K)Number | K023456 |
Product Classification |
Chamber, oxygen, topical, extremity - Product Code KPJ
|
Product | EPIFLO; Transdermal continuous oxygen therapy device; single use; disposable medical device. Model Number EPIFLO-15. Mfr.By: Neogenix, LLC, dba Ogenix, 3401 Enterprise Pkwy, Suite 340, Beachwood, OH 44122.
The EPIFLO System is intended to provide topical oxygen to treat 1.) skin ulcerations due to diabetes, venous stasis, post-surgical infections and gangrenous lesions 2.) Decubitus ulcers 3.) amputations/infected stumps 4.) skin grafts 5.) burns 6.) frostbite. |
Code Information |
AL 041 (only lot involved); model EPIFLO-15. |
Recalling Firm/ Manufacturer |
Ogenix Corporation 3401 Enterprise Pkwy Suite 340 Beachwood OH 44122-7341
|
For Additional Information Contact | Srinivasan Sarangapani 781-702-6732 |
Manufacturer Reason for Recall | Ogenix Initiated a voluntary recall for the EPIFLO-15 devices due to a mislabeling of the expiry date for this lot. Instead of March 2013, this lot carried May 2013 as the expiry date. |
FDA Determined Cause 2 | Labeling mix-ups |
Action | Ogenix sent a letter dated March 16, 2012 to all affected customers. The letter identified the product, the problem and the action to be taken by the customer. Customers were instructed to confirm the status of the devices and ship product with the recalled lot back to Ogenix and complete the form provided with the letter. |
Quantity in Commerce | 38 units |
Distribution | Worldwide Distribution-USA (nationwide) including the states of FL, MN, OH and the county of Turkey. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = KPJ
|